Quarterly report · Q2

Period2022-01-01 → 2022-06-30
Filed2022-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥840m2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥2.0bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥430m2021-01-01 → 2021-06-30Cons.Net sales
Operating income−¥312m2022-01-01 → 2022-06-30Cons.Operating income
Operating income−¥777m2021-01-01 → 2021-06-30Cons.Operating income
Ordinary income−¥306m2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥523m2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥775m2021-01-01 → 2021-06-30Cons.Ordinary income
Profit before tax−¥349m2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥781m2021-01-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)−¥359m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥534m2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥776m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income−¥359m2022-01-01 → 2022-06-30Cons.Profit loss
Net income−¥776m2021-01-01 → 2021-06-30Cons.Profit loss
Total assets¥5.2bnat 2022-06-30Cons.Assets
Total assets¥5.4bnat 2021-12-31Cons.Assets
Total assets¥3.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥792mat 2022-06-30Cons.Liabilities
Total liabilities¥1.1bnat 2021-12-31Cons.Liabilities
Net assets / equity¥4.4bnat 2022-06-30Cons.Net assets
Net assets / equity¥4.3bnat 2021-12-31Cons.Net assets
Net assets / equity¥3.1bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥3.8bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥4.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥3.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.2bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥585m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.5bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥963m2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥57m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥42m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥34m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥166m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.1bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥102m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-26.532022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.252022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-42.12021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-62.562021-01-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-39.462021-04-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio84.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥547m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥235m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥922m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥145m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 439
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember526032
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.0384
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember504500
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0369
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember438900
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0321
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember324100
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0237
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember297500
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0217
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember280641
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0205
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember273000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0199
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember250000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0182
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember183173
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0134
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember164000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0120
Number of shares heldCurrentQuarterInstant3241846
Shareholding ratioCurrentQuarterInstant0.2372
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember5100
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember136556
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember13655600
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember7600
Number of shares issued shares voting rightsCurrentQuarterInstant13668300
Number of voting rights issued shares voting rightsCurrentQuarterInstant136556
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member5100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member5100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0003
Number of shares held in own name treasury shares etcCurrentQuarterInstant5100
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant5100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0003
Cash and depositsPrior1YearInstant3817834000JPY
Cash and depositsCurrentQuarterInstant4684699000JPY
Accounts receivable tradePrior1YearInstant1243839000JPY
Accounts receivable tradeCurrentQuarterInstant129885000JPY
Merchandise and finished goodsPrior1YearInstant72514000JPY
Merchandise and finished goodsCurrentQuarterInstant79470000JPY
Work in processPrior1YearInstant7521000JPY
Work in processCurrentQuarterInstant6208000JPY
Raw materials and suppliesPrior1YearInstant30453000JPY
Raw materials and suppliesCurrentQuarterInstant27502000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass